{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_032112.3:c.7157C>G",
          "cDNA Change": {
            "transcript": "NM_032112.3",
            "ref": "C",
            "alt": "G",
            "position": "7157"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "E",
            "position": "2385"
          },
          "Description in input context": "c.7157C>G (p.R2385E)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005149"
  },
  "Experiment Method": [
    {
      "Assay Method": "Transfection studies",
      "Material used": {
        "Material Source": "Human cell lines",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using HEK293 cells."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_032112.3:c.7157C>G",
          "Conclusion": "Increased toxicity and apoptosis under oxidative stress",
          "Molecular Effect": "dominant-negative",
          "Result Description": "The Gly2385Arg variant was more toxic and associated with a higher rate of apoptosis under condition of oxidative stress."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Not mentioned in the literature, but standard practice is to perform biological replicates for such studies."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": ""
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": ""
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": ""
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not mentioned in the literature, but standard practice is to use ANOVA or similar methods."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": ""
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": ""
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "The experimental protocol used in the literature is generally used for studying Parkinson's disease."
      }
    }
  ]
}